TipRanks
Advertisement

SOVF - ETF AI Analysis

Compare

Top Page

SOVF

Sovereign's Capital Flourish Fund (SOVF)

Rating:70Neutral
Price Target:―
SOVF’s rating suggests it is a solid but not top-tier fund, with its quality driven by strong holdings like Qualcomm and Paycom, which show robust financial performance, positive earnings, and supportive long-term growth drivers. However, weaker names such as Repay Holdings, which faces profitability issues, bearish technical trends, and negative valuation signals, along with leveraged or overvalued positions like Vistra Energy, introduce risk. The main risk factor is exposure to several holdings with bearish technical signals, high leverage, or valuation concerns, which could increase volatility and limit upside if market conditions worsen.
Positive Factors
Recent Performance Momentum
The fund has shown positive returns over the past month, three months, and year-to-date, indicating recent upward momentum.
Sector Diversification Within the U.S.
Holdings are spread across technology, financials, industrials, health care, and several other sectors, which helps reduce the impact of weakness in any single industry.
Several Strong Top Holdings
Some of the largest positions, such as Molina Healthcare, Primerica, and Insperity, have delivered strong gains so far this year, supporting the fund’s overall results.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high, which means more of the returns are eaten up by fees compared with many low-cost ETFs.
Heavy U.S.-Only Focus
With almost all assets invested in U.S. companies, the fund offers little geographic diversification and is highly tied to the U.S. economy.
Mixed Performance Among Top Holdings
Several key positions, including Paycom, Alkami Technology, Grand Canyon Education, and Fiserv, have shown weak or negative performance this year, which could weigh on future returns if the trend continues.

SOVF vs. SPDR S&P 500 ETF (SPY)

SOVF Summary

SOVF, the Sovereign's Capital Flourish Fund, is a U.S. stock ETF that aims to cover the total market, from smaller up‑and‑coming businesses to larger, more established companies. It doesn’t track a single index, but instead mixes growth and value stocks across many sectors, with a big focus on technology and financial firms. Well-known names in the fund include Fiserv and Molina Healthcare. An investor might choose SOVF for broad diversification in one fund and the potential for long-term growth. However, its value can rise and fall with the overall stock market, especially tech and financial stocks.
How much will it cost me?The Sovereign's Capital Flourish Fund (SOVF) has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, aiming to balance growth and value strategies across a diverse range of market segments.
What would affect this ETF?The Sovereign's Capital Flourish Fund (SOVF) could benefit from growth in the technology and healthcare sectors, which make up a significant portion of its holdings, especially if innovation and demand in these areas continue to drive market performance. However, potential risks include economic slowdowns or rising interest rates, which could negatively impact financial and industrial stocks, as well as broader market volatility affecting its diversified portfolio. The fund's focus on U.S.-based companies also makes it sensitive to domestic regulatory changes and economic conditions.

SOVF Top 10 Holdings

SOVF leans heavily into U.S. tech and financial names, with Paycom and Qualcomm doing much of the heavy lifting. Paycom has been rising over the past few months, while Qualcomm’s steadier, mixed pattern still adds support. On the flip side, Alkami Technology is clearly dragging the fund, and lagging moves from Vistra and Euronet Worldwide aren’t helping. Health care exposure via Molina and Option Care Health is more mixed, offering some balance but not a strong tailwind. Overall, it’s a U.S.-centric, tech-tilted story with a few notable weak links.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Paycom5.20%$4.50M$9.90B13.48%
76
Outperform
Molina Healthcare4.21%$3.65M$10.17B-2.30%
71
Outperform
Qualcomm4.15%$3.60M$189.14B14.60%
80
Outperform
Option Care Health3.94%$3.41M$4.64B15.86%
73
Outperform
Grand Canyon Education3.79%$3.28M$4.06B-22.56%
74
Outperform
Repay Holdings3.68%$3.18M$335.98M-20.21%
51
Neutral
SPS Commerce3.53%$3.05M$2.92B-22.72%
77
Outperform
Vistra Corp3.43%$2.97M$55.96B-25.65%
65
Neutral
Euronet Worldwide2.86%$2.47M$2.34B-26.10%
66
Neutral
Alkami Technology2.79%$2.41M$1.51B-39.18%
61
Neutral

SOVF Technical Analysis

Technical Analysis Sentiment
Positive
Last Price―
Price Trends
50DMA
31.34
Negative
100DMA
30.33
Positive
200DMA
29.48
Positive
Market Momentum
MACD
-0.22
Negative
RSI
53.24
Neutral
STOCH
83.32
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SOVF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 30.62, equal to the 50-day MA of 31.34, and equal to the 200-day MA of 29.48, indicating a neutral trend. The MACD of -0.22 indicates Negative momentum. The RSI at 53.24 is Neutral, neither overbought nor oversold. The STOCH value of 83.32 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SOVF.

SOVF Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$86.60M0.75%
70
Neutral
――$94.55M0.87%
70
Outperform
――$90.48M0.85%
68
Neutral
――$89.20M0.59%
72
Outperform
――$85.60M0.65%
61
Neutral
――$82.19M0.65%
67
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SOVF
Sovereign's Capital Flourish Fund
30.95
1.57
5.34%
BAMD
Brookstone Dividend Stock ETF
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
PFOE
Pathfinder Focused Opportunities ETF
―
―
―
VAMO
Cambria Value & Momentum ETF
―
―
―
YALL
God Bless America ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement